Program at a Glance
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Tuesday March 28
8:00 – 12:00 | One Health and Blood Operator Workshop |
8:00 – 13:30 | AMMI Canada Council Meeting |
12:00 – 17:00 | AMMI Canada CRN Meeting |
12:30 – 17:00 | Trainees’ Day |
17:00 – 18:00 | Trainees’ Day Welcome Reception |
17:00 – 19:00 | CACMID Board Meeting |
18:00 – 19:30 | Paladin co-developed accredited learning activity with dinner Management of complicated Gram-positive infections in adult patients: current treatment challenges, unmet needs, and new treatment options |
Wednesday March 29
7:00 – 9:00 | Masterclasses New Tuberculosis Guidelines Lab Validation and Verification |
7:30 – 9:00 | Roche Canada co-developed accredited learning activity with breakfast Part I: Transplant viral load testing for BKV and EBV Part II: Mycoplasma genitalium infections: A challenge in Canada |
9:15 – 11:30 | Plenary Emerging Infectious Diseases in Canada – From Poop to Data to Diagnostics |
11:30 – 12:30 | Merck Canada co-developed accredited learning activity Management of Cytomegalovirus (CMV) in transplantation |
12:30 – 14:30 | Lunch and Exhibit Hall Open |
12:30 – 14:30 | In-Person Poster Presentations |
12:30 – 14:30 | AMMI Canada AGM and Sections Meeting |
14:45 – 15:45 | State of the Art Clinical Lecture Travel and Refugee Infectious Disease Update |
16:00 – 17:00 | GSK co-developed accredited learning activity Respiratory Syncytial Virus (RSV) in older adults: The under recognized burden |
17:00 – 18:00 | Merit and Association Awards Presentations |
18:00 – 18:30 | Special Lecture Stanley’s Dream: The Canadian Medical Expedition to Easter Island |
18:30 – 20:00 | Meet and Greet Welcome Reception Poster Viewing and Presentations |
Thursday March 30
7:00 – 9:00 | Masterclasses Genomics: Impact on IPAC and PH Optimizing options to end the epidemic: Harnessing the full array of antiretroviral agents for the treatment and prevention of HIV |
7:30 – 9:00 | Pfizer Canada co-developed accredited learning activity with breakfast Reduce the Risk: Optimizing care for patients at risk of COVID-19 |
9:15 – 11:15 | Plenary Antimicrobial Susceptibility Testing Updates: Making Sense of the Breakpoint Alphabet Soup and Rapid AST Options |
11:30 – 12:30 | Hologic co-developed accredited learning activity Complementing In Vitro Diagnostics (IVD) molecular testing menu options with Laboratory Developed Tests (LDTs) |
12:30 – 14:30 | Lunch and Exhibit Hall Open |
12:30 – 14:30 | In-Person Poster Presentations |
12:30 – 14:30 | CACMID AGM with special 90th anniversary lecture by Dr. Michael Mulvey |
14:45 – 15:45 | State of the Art Clinical Lecture Oral vs. IV Antibiotics: A Tough Pill to Swallow? |
16:00 – 17:00 | Student Oral Presentations Competition – Session A |
16:00 – 17:00 | Oral Presentations – Session B |
17:15 – 18:15 | Case Reports Symposium |
18:30 – 20:30 | AstraZenca unaccredited learning activity with dinner |
18:30 – 22:30 | JAMMI Editorial Board Meeting |
Friday March 31
6:30 – 8:30 | CFID Bug Run |
7:00 – 9:00 | Masterclasses How to Build a Research Program Communication with the Public/ Social Media |
7:30 – 9:00 | CSL Seqirus co-developed accredited learning activity with breakfast A critical look at influenza vaccine technologies: From bench to bedside |
9:15 – 10:15 | State of the Art Clinical Lecture Fundamentals of laboratory stewardship: essential components and easy wins |
10:30 – 11:30 | Oral Presentations – Session C |
10:30 – 11:30 | Oral Presentations – Session D |
11:30 – 13:30 | Lunch and In-Person Poster Presentations |
11:30 – 13:30 | CCM AGM |
11:30 – 13:30 | AMMI Canada Phage Working Group Meeting |
12:00 – 13:30 | Merck Canada co-developed accredited learning activity with lunch Pneumococcal vaccines for adults – past, present, and future |
12:00 – 13:30 | ViiV Healthcare Canada co-developed accredited learning activity with lunch When RWE reinforce RCT results: Review of the effectiveness and barrier to resistance of DTG/3TC in clinical practice |
13:45 – 14:45 | State of the Art Clinical Lecture Nuclear Medicine In Infectious Disease |
14:45 – 15:45 | Sanofi co-developed accredited learning activity RSV burden of disease in infants – A need for all infant protection |
16:00 – 18:00 | Plenary What’s Hot in Infectious Disease, Medical Microbiology, Stewardship and Infection Control Co-Developed with Canadian Foundation for Infectious Diseases (CFID) |
18:00 – 18:30 | Merit, Poster, and Research Awards Closing Remarks |
